Decreased T cell response to mitogen and increased anti-cytoplasmic antibody in drug-free schizophrenic patients

Iranian Journal of Immunology

Volumn 4, Issue 1, 2007, Pages 32-37

  Matloubi, Hedieh ^a   Vodjgani, Mohammad ^a,d   Nasehi, Abbass Ali ^b   Niknam, Mohammad Hossein ^a   Kazemnejad, Anoushirvan ^c   Salehi, Eisa ^a   Aboufazeli, Tahereh ^a   Gheflati, Zahra ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Iran Helal Institute of Applied Science and Technology   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ACA; ANA; CIC; Schizophrenia; T cell proliferation

Indexed keywords

1 (3,4 DIMETHOXYPHENYL) 3 (3 ETHYLVALERYL) 4 HYDROXY 6,7,8 TRIMETHOXY 2 NAPHTHOIC ACID METHYL ESTER; ANTINUCLEAR ANTIBODY; MACROGOL; PHYTOHEMAGGLUTININ;

ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOCYTE PROLIFERATION; MALE; NITROBLUE TETRAZOLIUM TEST; PERIPHERAL BLOOD MONONUCLEAR CELL; SCHIZOPHRENIA; T LYMPHOCYTE;

EID: 34249012110     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gaughran F. Immunity and schizophrenia: autoimmunity, cytokines, and immune responses. Int Rev Neurobiol. 2002; 52:275-302.
2. Rothermundt M, Arolt V, Bayer TA. Review of immunological and immunopathological findings in schizophrenia. Brain Behav.Immun. 2001; 15:319-39.
3. Kovaleva ES, Prilipko LL, Tsutsul'kovskaia MIa. Dependence of the peripheral blood lymphocyte reaction of schizophrenia patients to concanavalin A stimulation on the clinical parameters of the pathological process. Zh.Nevropatol.Psikhiatr.Im S.S.Korsakova. 1980; 80 :71-3.
4. Fetisova TK. Proliferative response of schizophrenic patient's peripheral blood lymphocytes. Zh.Nevropatol.Psikhiatr.Im S.S.Korsakova. 1978; 78:867-71.
5. Pivovarova AI, Koliaskina GI. Effect of different doses of phytomitogens on blood lymphocyte proliferation in schizophrenia. Biull.Eksp.Biol.Med. 1980; 90:552-4.
6. Chengappa KN, Ganguli R, Yang ZW, Shurin G, Brar JS, Rabin BS .Impaired mitogen (PHA) responsiveness and increased autoantibodies in Caucasian schizophrenic patients with the HLA B8/DR3 phenotype. Biol.Psychiatry. 1995; 37:546-9.
7. Monteleone P, Valente B, Maj M, Kemali D. Reduced lymphocyte response to PHA and OKT3 in drug-free and neuroleptictreated chronic schizophrenics. Biol.Psychiatry.1991; 30:201- 4.
8. Leykin I, Mayer R, Shinitzky M. Short and long-term immunosuppressive effects of clozapine and haloperidol. Immunopharmacology. 1997; 37:75-86.
9. Villemain F, Chatenoud L, Galinowski A, Homo-Delarche F, Ginestet D, Loo H et al. Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am.J.Psychiatry. 1989; 146:609-16.
10. Ganguli R, Rabin BS, Brar JS. Antinuclear and gastric parietal cell autoantibodies in schizophrenic patients. Biol.Psychiatry. 1992; 32:735-8.
11. Yannitsi SG, Manoussakis MN, Mavridis AK, Tzioufas AG, Loukas SB, Plataris GK et al. Factors related to the presence of autoantibodies in patients with chronic mental disorders. Biol.Psychiatry 1990; 27:747-56.
12. Villemain F, Magnin M, Feuillet-Fieux MN, Zarifian E, Loo H, Bach JF. Anti-histone antibodies in schizophrenia and affective disorders. Psychiatry Res. 1988 Apr;24:53-60.
13. Spivak B, Radwan M, Bartur P, Mester R, Weizman A. Antinuclear autoantibodies in chronic schizophrenia. Acta Psychiatr Scand. 1995; 92:266-9.
14. Sirota P, Firer MA, Schild K, Tanay A, Elizur A, Meytes D et al .Autoantibodies to DNA in multicase families with schizophrenia. Biol Psychiatry. 1993;33: 450-5.
15. Zorrilla EP, Cannon TD, Gur RE, Kessler J. Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease? Biol.Psychiatry. 1996; 40:825-33.
16. Funauchi M, Yamagata T, Nozaki Y, Sugiyama M, Ikoma SY, Kinoshita K et al. A case of systemic lupus erythematosus that manifested in the course of schizophrenia. Scand.J.Rheumatol. 2002; 31:374- 6.
17. Dvorakova M, Zvolsky P, Jandova A. The LDH virus and changes in cellular immunity in schizophrenics and their relatives. Sb Lek. 1990; 92 :305-10.
18. Ma QH, Ju YL , Zhang ZL. Immunological study of inefficiency schizophrenics with deficiency syndrome treated with xin shen ling. Zhong.Xi.Yi.Jie.He.Za Zhi. 1991; 11:215-7.
19. Hakobyan S, Avetisyan G, Boyajyan A, Torosyan S, Khachatryan G, Tatevosyan S. Circulating immune complexes in blood of patients with positive family history of schizophrenia. Dokl .Biochem .Biophys. 2001; 380:343-4.
20. Koliaskina GI, Sekirina TP, Androsova LV, Kushner SG, Vasil'eva EF, Burbaeva OA et al. A change of immune profile of patients with schizophrenia during treatment. Zh.Nevrol.Psikhiatr.Im S.S.Korsakova .2004; 104:39-45.
21. Fontana A, Storck U, Angst J, Dubs R, Abegg A, Grob PJ. An immunological basis of schizophrenia and affective disorders? Neuropsychobiology. 1980; 6:284 - 9.
22. Vetlugina TP, Ivanova SA, Logvinovich GV, Vasi'leva OA. Phagocytosis of immune complexes by leukocytes in patients with schizophrenia. Zh Nevropatol Psikhiatr Im S S Korsakova. 1989; 89:102-4.
23. Evans DT, Giles M, Horne DJ, d'Apice AJ, Riglar A, Toh BH.Cerebral lupus erythematosus responding to plasmaphaeresis. Postgrad Med J. 1981; 57:247-51.
24. Coppo R, De Marchi M, Basolo B, Martina G, Rollino C, Boero R et al. Specificity, sensitivity and reproducibility of 2 methods of determining serum immunocomplexes (solid-phase C1q and polyethylene glycol precipitation) Arch Sci Med (Torino). 1982; 139:381-92.
25. Vetlugina TP, Ivanova SA, Logvinovich GV, Vasi'leva OA. Phagocytosis of immune complexes by leukocytes in patients with schizophrenia.Zh Nevropatol Psikhiatr Im S S Korsakova. 1989; 89: 102-4.